Search

everythinglearnresearchcommunity

for

Search:↓

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Cannabinoids may help treat various skin conditions.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Cannabinoids might help treat skin problems but more research is needed to be sure.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking interferon-gamma might help treat various autoimmune diseases.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

TNF-alpha inhibitors can cause various immune-related skin issues.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Ascorbic acid derivatives improve drug delivery systems.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.